← Back to Search

Device

Tongue Stabilizing Device Treatment for Obstructive Sleep Apnea

N/A
Waitlist Available
Led By Fernanda R Almeida, DDS, MSc, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 2-6 months of tsd treatment follow up
Awards & highlights

Study Summary

The coordination of swallowing and breathing is an important mechanism because the route for air and deglutition is partly shared in the pharynx. Tongue Stabilizing Device (TSD) is a preformed appliance for Obstructive Sleep Apnea (OSA) that protrudes the tongue and improves upper airway structure and function during sleep. Investigators will attempt to assess efficacy of TSD therapy on OSA and the physiological change of swallowing and breathing routes in OSA patients during sleep.

Eligible Conditions
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 2-6 months of tsd treatment follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 2-6 months of tsd treatment follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Apnea-hypopnea index
Frequency of swallowing
Secondary outcome measures
Breathing route
Compliance (Measuring adherence (hours/nights and nights/week of intervention use))
Epworth Sleepiness Scale (ESS) questionnaire responses.
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tongue Stabilizing Device TreatmentExperimental Treatment1 Intervention
Tongue Stabilizing Device (TSD) is a preformed appliance for OSA that protrudes the tongue and improves upper airway structure and function during sleep.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tongue Stabilizing Device (TSD)
2015
N/A
~50

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,975 Total Patients Enrolled
Fernanda R Almeida, DDS, MSc, PhDPrincipal InvestigatorUniversity of British Columbia
1 Previous Clinical Trials
79 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025